ORGN 372 |
| Artemisinin, with its unique endoperoxide pharmacophore, is a critical component of front-line malaria treatments and an experimental cancer drug. Recent advances in synthetic organic chemistry targeted towards improved access to artemisinin and related compounds will be presented, including the develepment of a gold(III)-catalyzed Meyer–Schuster rearrangement for the olefination of hindered ketones. |
|
New Reactions and Methodology
8:00 AM-12:00 PM, Tuesday, 12 September 2006 Moscone Center -- Room 133, Oral
Division of Organic Chemistry |